Corpus Callosum Agenesis Neuronopathy

Corpus Callosum Agenesis Neuronopathy is a neurodegenerative disorder characterized by severe progressive sensorimotor neuropathy beginning in infancy. Here is the latest research.

January 6, 2022

Prenatal diagnosis of Aicardi syndrome based on a suggestive imaging pattern: A multicenter case-series.

Prenatal Diagnosis
Léo PomarLaurent Guibaud
January 5, 2022

The diagnostic challenges of congenital mirror movements and hand stereotypies in a case with TUBB3-associated tubulinopathy.

Acta neurologica Belgica
Nurşah Yeniay SütSerap Teber
January 4, 2022
Case Report

The role of whole exome sequencing in the UBE3A point mutation of Angelman Syndrome: A case report.

Annals of Medicine and Surgery
Agung TrionoElisabeth Siti Herini
December 29, 2021
Preprint
Open Access

Increased persuadability and credulity in people with corpus callosum dysgenesis

MedRxiv : the Preprint Server for Health Sciences
Linda J RichardsP. Dayan
December 27, 2021
Review

Rhomboencephalosynapsis: Review of the Literature.

World Neurosurgery
Mohammed A FoudaAlan R Cohen
December 24, 2021

Microcephaly gene Cenpj regulates axonal growth in cortical neurons through microtubule destabilization.

Journal of Neurochemistry
Pamela Meneses IackPatricia P Garcez
December 15, 2021

Fetal central nervous system anomalies according to RT-PCR and trimester of maternal infection with Zika virus: A prospective cohort study.

Acta Obstetricia Et Gynecologica Scandinavica
Luz Ángela Gutiérrez-SánchezLuz Stella Pinilla García
December 16, 2021

Variants in ADD1 cause intellectual disability, corpus callosum dysgenesis, and ventriculomegaly in humans.

Genetics in Medicine : Official Journal of the American College of Medical Genetics
Cai QiXiaochang Zhang
November 13, 2021
Preprint
Open Access

Zika virus infection during development impairs the formation of corpus callosum by disturbing axon guidance and growth of callosal neurons.

BioRxiv : the Preprint Server for Biology
Raissa R ChristoffPatricia P Garcez
October 29, 2021
Case Report

Expanding the phenotype of SLC12A6-associated sensorimotor neuropathy.

BMJ Case Reports
Petya Bogdanova-MihaylovaSinéad M Murphy
October 28, 2021
Open Access

Corpus callosum dysgenesis causes novel patterns of structural and functional brain connectivity.

Brain Communications
Diego SzczupakFernanda Tovar-Moll
October 4, 2021

The Dynamics of Axon Bifurcation Development in the Cerebral Cortex of Typical and Acallosal Mice.

Neuroscience
Danielle RayêePatricia P Garcez
August 19, 2021

The first Chinese case of Vici syndrome with novel compound heterozygous sequence variants in EPG5.

International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience
Liping DongShiguo Liu

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2022 Meta ULC. All rights reserved
/feed-previews/corpus-callosum-agenesis-neuronopathy/fbb95520-b3d7-40e2-be26-15715eef95a6